The analgesic efficacy of dexamethasone added to levobupivacaine in ultrasound-guided transversus abdominis plane block for abdominal hysterectomy or abdominal hysterectomy with saplingo-oophorectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20150917002

Enrollment

Registered

2015-09-17

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after abdominal hysterectomy or abdominal hysterectomy with saplingo&#45

Interventions

0.25% Levobupivacaine + NSS,0.25% Levobupivacaine + dexamethasone 4 mg,0.25% Levobupivacaine + dexamethasone 8 mg

Placebo Comparator Drug,Experimental Drug,Experimental Drug

Placebo,Dexamethasone 4 mg,Dexamethasone 8 mg

Eligibility

Sex/Gender

Female

Age

18 Years to 0 Years

Inclusion criteria

Inclusion criteria: Patient undergoing abdominal hysterectomy or abdominal hysterectomy with saplingo-oophorectomy

Exclusion criteria

Exclusion criteria: Previous abdominal surgery Allergy to levobupivacaine, dexamethasone or morphine Chronic pain Diabetes mallitus Morbid obesity (BMI > 35)

Design outcomes

Primary

Measure	Time frame
Time to first analgesic requirement First to to analgesic requirement The first time that the patient required morphine after the operation	—

Secondary

Measure	Time frame
Pain score 48 hours Verbal numerating rating scale,Total morphine consumption 48 hours Mg	—

Countries

Thailand

Contacts

Public ContactOrarat Karnjanawanichkul

University

Oraratx@yahoo.com66894678010

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026

The analgesic efficacy of dexamethasone added to levobupivacaine in ultrasound&#45;guided transversus abdominis plane block for abdominal hysterectomy or abdominal hysterectomy with saplingo&#45;oophorectomy